Transient EZH2 suppression by Tazemetostat during <i>in vitro</i> expansion maintains T cell stemness and improves adoptive T cell therapy
Yingqin Hou(Scripps Research Institute), Peng Wu(Scripps Research Institute), Isaraphorn Pratumchai(Scripps Research Institute), Evan W. Weber(Stanford University), Yujie Shi(Zhengzhou University), John R. Teijaro(Scripps Research Institute), Wenjian Wang(Fudan University), Brandon Dinner(Scripps Research Institute), Ke Qin(Scripps Research Institute), Jaroslav Žák(Scripps Research Institute)
Cited by 5
Related Papers
Efficiency and Fidelity in a Click‐Chemistry Route to Triazole Dendrimers by the Copper(<scp>I</scp>)‐Catalyzed Ligation of Azides and Alkynes
|Angewandte Chemie International Edition|2004|1.2k
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
|Proceedings of the National Academy of Sciences|2012|594
Pharmacologic control of CAR-T cell function using dasatinib
|Blood Advances|2019|229
FOXO1 is a master regulator of memory programming in CAR T cells
|Nature|2024|189